Klaassen, Z. et al. 2017. Contemporary cost-consequence analysis of blue light cystoscopy with hexaminolevulinate in non-muscle-invasive bladder cancer. Canadian Urological Association Journal. 11, 6 (Jun. 2017), 173–81. DOI:https://doi.org/10.5489/cuaj.4568.